Abstract
The value of rheumatoid factor (RF) isotypes for assessing rheumatoid arthritis (RA) remains debatable. In this study, we have examined the relationships between RF isotypes and disease activity and severity in RA patients. Sixty-two patients with RA, 48 women and 14 men, were studied. RF was measured by nephelometry (RF–N) and IgG–, IgA–, and IgM–RF isotypes were measured using enzyme-linked immunosorbent assay. Serum C-reactive protein and erythrocyte sedimentation rate were also determined. The patients were classified according to disease activity, joint damage, functional status, and presence of pulmonary involvement, rheumatoid nodule, and secondary Sjögren’s syndrome. Although the patients with active disease had significantly higher IgA–RF and IgM–RF levels compared to inactive patients, IgA–RF and IgM–RF were not found to be independently associated with disease activity in multivariate analysis. In patients with severe joint damage, IgA–RF and RF–N were significantly higher than those of the other patients. Multiple regression analysis showed that IgA–RF was the unique variable independently associated to severe joint damage. The patients with class III and IV functional index had significantly higher IgM–RF, IgA–RF, and RF–N levels compared to the patients with class I and II functional index; however, RFs were not significantly associated with functional status in multivariate analysis. IgA–RF and IgM–RF were significantly associated with pulmonary involvement and rheumatoid nodule, respectively. No significant associations were found between RF isotypes and secondary Sjögren’s syndrome. Our results suggest that the clinical usefulness of IgA and IgM isotypes is better than RF–N. Elevated IgA–RF may be a marker of erosive disease. The usefulness of RF isotypes for monitoring disease activity or functional status appears to be limited.
Similar content being viewed by others
References
Bartfeld H (1969) Distribution of rheumatoid factor activity in nonrheumatoid states. Ann NY Acad Sci 168:30–40
Silvestris F, Anderson W, Goodwin JS, Williams RC Jr (1985) Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 35:234–244
Van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, Van’t Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiologic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31:519–525
Möttenen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P (1998) Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with ‘sawtooth’ strategy. Ann Rheum Dis 57:533–539
Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 42:939–946
Tarkowski A, Nilsson LA (1983) Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol 12:129–135
Möttönen T, Hannonen P, Jokinen I, Arvilommi M, Oka M (1988) Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritis. Scand J Rheumatol 75(Suppl):244–249
Jonsson T, Thorsteinsson J, Kolbeinsson A, Jonasdottir E, Sigfusson N, Valdimarsson H (1992) Population study of the importance of rheumatoid factor isotypes in adult. Ann Rheum Dis 51:863–868
van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 51:1029–1035
van Leeuwen MA, Westra J, van Riel PLCM, Limburg PC, van Rijswijk MH (1995) IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 24:146–153
Houssien DA, Jonsson T, Davies E, Scott DL (1998) Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Comparative effects of different antigens. Scand J Rheumatol 27:46–53
Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677–680
Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427–430
Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC (1987) IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 46:65–71
Eberhardt KB, Svensson B, Truedsson L, Wollheim FA (1988) The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis—no relationship with erosions or disease activity. J Rheumatol 15:1070–1074
McDougal JS, Hubbard M, McDuffie FC, Strobel PL, Smith SJ, Bass N, Goldman JA, Hartman S, Myerson G, Miller S, Morales R, Wilson CH Jr (1982) Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity in rheumatoid arthritis. Arthritis Rheum 25:1156–1166
Withrington RH, Teitsson I, Valdimarsson H, Seifert MH (1984) Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 43:679–685
Highton J, Hessian PA, Small B, Palmer DG (1985) An assessment of the diagnostic value of quantitative measurements of IgA rheumatoid factor. J Rheumatol 12:854–858
Westedt ML, Herbrink P, Molenaar JL, de Vries E, Verlaan P, Stijnen T, Cats A, Lindeman J (1985) Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int 5:209–214
March RE, Kirwan JR, Reeback JS, Holborow EJ (1987) IgM, IgG and IgA rheumatoid factors (antiglobulins) in early rheumatoid arthritis and their production of articular index over one year. Scand J Rheumatol 16:407–411
Carpenter AB, Smailer S (1989) Measurement of rheumatoid factor isotypes in the clinical laboratory. Immunol Invest 18:765–773
Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Yamada Y, Toumatu J (1998) Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren’s syndrome and rheumatoid arthritis. Clin Exp Rheumatol 16:709–715
Luthviksson BR, Jonsson T, Erlendsson K, Sigfusson A (1992) Disease manifestations in patients with isolated elevation of IgA rheumatoid factor. Scand J Rheumatol 21:1–4
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308–1315
Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 8:481–491
Hochberg MC, Chang RW, Dwash I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502
Jonsson T, Valdimarsson H (1992) Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol Int 12:111–113
Jonsson T, Valdimarsson H (1993) Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 52:161–164
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ateş, A., Kinikli, G., Turgay, M. et al. Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study. Clin Rheumatol 26, 538–545 (2007). https://doi.org/10.1007/s10067-006-0343-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0343-x